Among these, 11 genes—including BIRC3, BTG1, CCR7, HOXC13, IL7R, IRF1, MECOM, NFKB2, NFKBIA, NFKBIE, and WAS —emerged as key players in tumor progression and immune regulation. This evidence concerns the gene NFKB2 and neoplasm.